MacroGenics, Inc. ( MGNX) - Stock Earnings
MGNX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 16.8 million USD | 72.8 million USD |
| 2025Q4 | -14.2 million USD | 41.2 million USD |
| 2026Q1 | -36.8 million USD | 20.8 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
MGNX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -9.1 million USD | 57.2 million USD |
| 2024 | -67.0 million USD | 148.3 million USD |
| 2025 | -74.6 million USD | 149.5 million USD |
| 2026 Est. | — | — |
MGNX
Price: $3.94
52 week price:
Earnings Per Share: -1.11 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 382181
Ebitda: -45.8 millionMarket Capitalization: 248.5 million